Evaluation of inductive effects of different concentrations of cyclosporine A on MMP-1, MMP-2, MMP-3, TIMP-1, and TIMP-2 in fetal and adult human gingival fibroblasts

References

[1] Tarantino A, Aroldi A, Stucchi L, Montagnino G, Mascaretti L, Vegeto A, et al. A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation. Transplantation 1991;52:53–7.10.1097/00007890-199107000-00011Search in Google Scholar PubMed

[2] Wright G, Wilbur R, Hosey M. Cyclosporin-induced gingival overgrowth in children. Int J Paediatr Dent 2005;15:403–11.10.1111/j.1365-263X.2005.00676.xSearch in Google Scholar PubMed

[3] Bolzani G, Coletta RD, Júnior HM, De Almeida OP, Graner E. Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblasts. J Periodontal Res 2000;35:51–8.10.1034/j.1600-0765.2000.035001051.xSearch in Google Scholar PubMed

[4] Trackman P, Kantarci A. Molecular and clinical aspects of drug-induced gingival overgrowth. J Dent Res 2015;94:540–6.10.1177/0022034515571265Search in Google Scholar PubMed PubMed Central

[5] Rezzani R. Cyclosporine A and adverse effects on organs: histochemical studies. Prog Histochem Cytochem 2004;39:85–128.10.1016/j.proghi.2004.04.001Search in Google Scholar PubMed

[6] Nagata T, Ninomiya M, Mihara C, Kido J, Nishikawa S, Kataoka M. Etiology of drug-induced gingival overgrowth. Curr Issues Peridontics. 2016;7:37–44.Search in Google Scholar

[7] Boltchi FE, Rees TD, Iacopino AM. Cyclosporine A-induced gingival overgrowth: a comprehensive review. Quintessence Int. 1999;30:775–83.Search in Google Scholar

[8] Margiotta V, Pizzo I, Pizzo G, Barbaro A. Cyclosporin-and nifedipine-induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters, and HLA-antigens. J Oral Pathol Med 1996;25:128–34.10.1111/j.1600-0714.1996.tb00207.xSearch in Google Scholar PubMed

[9] Friskopp J, Klintmalm G. Gingival enlargement. A comparison between cyclosporine and azathioprine treated renal allograft recipients. Swed Dent J 1985;10:85–92.Search in Google Scholar

[10] Kantarci A, Cebeci I, Tuncer Ö, Çarin M, Firatli E. Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia. J Periodontol 1999;70:587–93.10.1902/jop.1999.70.6.587Search in Google Scholar PubMed

[11] Ilgenli T, Atilla G, Baylas H. Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results. J Periodontol 1999;70:967–72.10.1902/jop.1999.70.9.967Search in Google Scholar PubMed

[12] Dannewitz B, Edrich C, Tomakidi P, Kohl A, Gabbert O, Eickholz P, et al. Elevated gene expression of MMP-1, MMP-10, and TIMP-1 reveal changes of molecules involved in turn-over of extracellular matrix in cyclosporine-induced gingival overgrowth. Cell Tissue Res 2006;325:513–22.10.1007/s00441-006-0200-xSearch in Google Scholar PubMed

[13] Johanson M, Zhao XR, Huynh-Ba G, Villar CC. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases, and inflammation in cyclosporine A–induced gingival enlargement: a pilot in vitro study using a three-dimensional model of the human oral mucosa. J Periodontol 2013;84:634–40.10.1902/jop.2012.120224Search in Google Scholar PubMed

[14] Ma S, Liu W, Liu P, Liu J, Chen L, Qin C. Tanshinone IIA treatment alleviated the rat gingival connective tissue overgrowth induced by cyclosporine A. J Periodontal Res 2016;51:567–76.10.1111/jre.12335Search in Google Scholar

[15] Zebrowski EJ, Pylypas SP, Odlum O, Johnson RB. Comparative metabolism of 3H-glucosamine by fibroblast populations exposed to cyclosporine. J Periodontol 1994;65:565–7.10.1902/jop.1994.65.6.565Search in Google Scholar

[16] Kitamura K, Morisaki I, Adachi C, Kato K, Mihara J, Sobue S, et al. Gingival overgrowth induced by cyclosporin A in rats. Arch Oral Biol 1990;35:483–6.10.1016/0003-9969(90)90213-TSearch in Google Scholar

[17] Reynolds J. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis 1996;2:70–6.10.1111/j.1601-0825.1996.tb00206.xSearch in Google Scholar

[18] Sukkar T, Thomason J, Cawston T, Lakey R, Jones D, Catterall J, et al. Gingival fibroblasts grown from cyclosporin-treated patients show a reduced production of matrix metalloproteinase-1 (MMP-1) compared with normal gingival fibroblasts, and cyclosporin down-regulates the production of MMP-1 stimulated by pro-inflammatory cytokines. J Periodontal Res 2007;42:580–8.10.1111/j.1600-0765.2007.00986.xSearch in Google Scholar

[19] Kelly EA, Jarjour NN. Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med 2003;9:28–33.10.1097/00063198-200301000-00005Search in Google Scholar

[20] Yurchenko V, Pushkarsky T, Li J-H, Dai WW, Sherry B, Bukrinsky M. Regulation of CD147 cell surface expression involvement of the proline residue in the CD147 transmembrane domain. J Biol Chem 2005;280:17013–9.10.1074/jbc.M412851200Search in Google Scholar

[21] Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64:474–84.10.1902/jop.1993.64.5.474Search in Google Scholar

[22] Havemose-Poulsen A, Holmstrup P. Factors affecting IL-1-mediated collagen metabolism by fibroblasts and the pathogenesis of periodontal disease: a review of the literature. Crit Rev Oral Biol Med 1997;8:217–36.10.1177/10454411970080020801Search in Google Scholar

[23] Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463–516.10.1146/annurev.cellbio.17.1.463Search in Google Scholar

[24] Windsor LJ, Grenett H, Birkedal-Hansen B, Bodden MK, Engler JA, Birkedal-Hansen H. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J Biol Chem 1993;268:17341–7.10.1016/S0021-9258(19)85340-1Search in Google Scholar

[25] Kuo PJ, Tu HP, Chin YT, Lu SH, Chiang CY, Chen RY, et al. Cyclosporine-A inhibits MMP-2 and-9 activities in the presence of porphyromonasgingivalis lipopolysaccharide: an experiment in human gingival fibroblast and U937 macrophage co-culture. J Periodontal Res 2012;47:431–8.10.1111/j.1600-0765.2011.01450.xSearch in Google Scholar

[26] Sobral L, Aseredo F, Agostini M, Bufalino A, Pereira M, Graner E, et al. Molecular events associated with cyclosporine A-induced gingival overgrowth are attenuated by Smad7 overexpression in fibroblasts. J Periodontal Res 2012;47:149–58.10.1111/j.1600-0765.2011.01412.xSearch in Google Scholar

[27] Ogata Y, Enghild J, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992;267:3581–4.10.1016/S0021-9258(19)50563-4Search in Google Scholar

[28] Unemori EN, Bair M, Bauer E, Amento E. Stromelysin expression regulates collagenase activation in human fibroblasts. Dissociable control of two metalloproteinases by interferon-gamma. J Biol Chem 1991;266:23477–82.10.1016/S0021-9258(18)54522-1Search in Google Scholar

[29] Cotrim P, De Andrade C, Martelli-Junior H, Graner E, Sauk J, Coletta R. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-β1 autocrine stimulation. J Periodontol 2002;73:1313–22.10.1902/jop.2002.73.11.1313Search in Google Scholar

[30] Gomez D, Alonso D, Yoshiji H, Thorgeirsson U. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:111–22.Search in Google Scholar

[31] Seymour R, Ellis J, Thomason J. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000;27:217–23.10.1034/j.1600-051x.2000.027004217.xSearch in Google Scholar

[32] Vahabi S, Salman BN, Rezazadeh F, Namdari M. Effects of cyclosporine and phenytoin on biomarker expressions in gingival fibroblasts of children and adults: an in vitro study. J Basic Clin Physiol Pharmacol 2014;25:167–73.10.1515/jbcpp-2013-0003Search in Google Scholar

[33] Uzel MI, Kantarci A, Hong H-H, Uygur C, Sheff MC, Firatli E, et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol 2001;72:921–31.10.1902/jop.2001.72.7.921Search in Google Scholar

[34] Saus J, Quinones S, Otani Y, Nagase H, Harris E, Kurkinen M. The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin. J Biol Chem 1988;263:6742–5.10.1016/S0021-9258(18)68705-8Search in Google Scholar

[35] Nazemisalman B, Vahabi S, Bandehpour M, Aryankia A. Phenytoin effects on inflammatory mediator’s production by gingival fibroblasts: a comparative study in children and adults. Oral Health Dent Manag 2014;13:847–53.Search in Google Scholar

[36] Vahabi S, Moslemi M, Nazemisalman B, Yadegari Z. Phenytoin effects on proliferation and induction of IL1β and PGE2 in pediatric and adults’ gingival fibroblasts. Open J Stomatolo 2014;4:452.10.4236/ojst.2014.49061Search in Google Scholar

[37] Vahabi S, Nazemisalman B, Golpaigani MV, Ahmadi A. Effect of phenytoin and age on gingival fibroblast enzymes. J Dent (Tehran) 2014;11:270.Search in Google Scholar

[38] Vahabi S, Salman BN, Pourgolshani P. Effect of phenytoin and cyclosporine on IL-17 production by gingival fibroblasts of adults and children. J Periodontol Implant Dent 2015;7:1–6.10.15171/jpid.2015.001Search in Google Scholar

[39] Hyland PL, Traynor PS, Myrillas TT, Marley JJ, Linden GJ, Winter P, et al. The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts. J Periodontol 2003;74:437–45.10.1902/jop.2003.74.4.437Search in Google Scholar PubMed

[40] Kusztal M, Radwan-Oczko M, Kościelska-Kasprzak K, Boratyńska M, Patrzałek D, Klinger M. Possible association of CTLA-4 gene polymorphism with cyclosporine-induced gingival overgrowth in kidney transplant recipients. Transplant Proc 2007;39:2763–5.10.1016/j.transproceed.2007.09.002Search in Google Scholar PubMed

[41] Luo Y, Gong Y, Yu Y. Interleukin-10 gene promoter polymorphisms are associated with cyclosporin A-induced gingival overgrowth in renal transplant patients. Arch Oral Biol 2013;58:1199–207.10.1016/j.archoralbio.2013.03.015Search in Google Scholar PubMed

[42] Ogino M, Kido J-i, Bando M, Hayashi N, Wada C, Nagata T, et al. α2 Integrin+ 807 polymorphism in drug-induced gingival overgrowth. J Dent Res 2005;84:1183–6.10.1177/154405910508401217Search in Google Scholar PubMed